RRM2 and hepatocellular carcinoma: Xu et al. reported that miR-582–3p targets ribonucleotide reductase regulatory subunit M2 (RRM2) and inhibits the tumorigenesis of HCC by regulating the Wnt/β-catenin signaling pathway [46].